Non Alcoholic Fatty Liver Disease is related to insulin resistance and the metabolic syndrome and may respond to treatments originally developed for other insulin-resistant states (e.g. diabetes mellitus type 2) such as weight loss, metformin, and thiazolidinediones. Non-alcoholic steatohepatitis (NASH) is the most extreme form of NAFLD, and is regarded as a major cause of cirrhosis of the liver of unknown cause.NAFLD prevalence in Spain is very high. Male sex, age, metabolic syndrome, insulin resistance and alanine aminotransferase are the factors associated with NAFLD. Furthermore, studies should be carried out with respect to the controversial effect of alcohol on NAFLD.
No standard treatment for nonalcoholic fatty liver disease exists. Instead, doctors typically work to treat the risk factors that contribute to the liver disease. For instance, if obese, doctor can help to lose weight through diet, exercise and, in some cases, medications and surgery.To reduce the risk of nonalcoholic fatty liver disease:Choose a healthy diet, Maintain a healthy weight, Exercise most days of the week. Get an OK from your doctor first if you haven't been exercising regularly.